Description
Learning Objectives
Upon completion of this activity, the learner will be able to:
- Describe the challenges of providing 131I-Metaiodobenzylguanidine (131I-MIBG) therapy to children with neuroblastoma.
- Describe the methods used to conduct this study, including data analysis techniques.
- Differentiate key findings related to the child and the parent experience identified in this study.
- Analyze and apply the study’s findings to improve care of children receiving 131I-MIBG therapy.
Individual Learning Needs Assessment (ILNA) Coding
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. You may claim 1 CNE in one of the following ILNA categories: Care of the Pediatric Hem/Onc Patient OR Pediatric Hematology and Oncology Nursing Practice.
Please reach out to the Education Team at education@aphon.org with your name, the email associated with your APHON account, and the above ILNA category you would like to have reflected on your certificate and APHON can update your completion certificate to reflect your choice.
